About the Authors

Guinevere Q. Lee

Affiliations BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, University of British Columbia, Vancouver, BC, Canada

Winnie Dong

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada

Theresa Mo

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada

David J. H. F. Knapp

Affiliations BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, University of British Columbia, Vancouver, BC, Canada

Chanson J. Brumme

Affiliations BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, University of British Columbia, Vancouver, BC, Canada

Conan K. Woods

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada

Steve Kanters

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada

Benita Yip

Affiliation BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada

P. Richard Harrigan

prharrigan@cfenet.ubc.ca

Affiliations BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, University of British Columbia, Vancouver, BC, Canada

Competing Interests

The authors have the following interests: This study was funded by ViiV Healthcare. PRH has received consulting fees from ViiV/Pfizer, Quest, Selah and Tobira, holds stock in Merck, and is a PLOS ONE Editorial Board member. These do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: GQL PRH. Performed the experiments: GQL WD TM DJHFK. Analyzed the data: GQL CB CW SK BY PRH. Wrote the paper: GQL.